The incidence of contralateral breast cancer is high and constant with age, around five per 1000 women who had a primary breast cancer. For other neoplasms, the pattern of incidence of second primary neoplasms with age is less known, particularly as for only a few neoplasms the site of origin is not totally removed, and hence remains at risk of a second primary. Using the dataset from the Cancer Registry of the Swiss Canton of Vaud, we show that the incidence of second neoplasms is constant with age also after oral and pharyngeal, colorectal cancers, cutaneous malignant melanoma (CMM) and basal cell carcinoma. The incidence of first primary oral and pharyngeal cancer increased 20-fold between age 30-39 and 70-89 years, whereas the incidence of second neoplasms did not increase with age. Rates of second colorectal cancer remained relatively constant with age, between 2.5 per 1000 at age 40-59 years and 3.8 per 1000 at 70 years and above. Likewise, for CMM, the age-specific incidence rates of second primary CMM did not vary, ranging between 1 and 2.5 per 1000 in various subsequent age groups. The pattern of incidence for second basal cell carcinoma was similar, with no clear rise with age. These patterns are compatible with the occurrence of a single mutational event in a population of susceptible individuals. A possible implication of these observations is that a variable, but potentially large, proportion of cancers arise in very highrisk individuals and the incidence, on average, increases at a high constant level at a predetermined age.
It has long been noticed (Robbins and Berg, 1964; Prior and Waterhouse, 1978; Harvey and Brinton, 1985) that the relative risk (RR) of second primary cancers is higher at younger ages, and tends to decline with advancing age. Thus, compared with expected numbers based on the general population, the RR of second breast cancer among nearly 200 000 women registered with primary breast cancer in Birmingham between 1936 and 1962 was 5.6 at age 25-44 years, 3.7 at age 45-59 years and 1.8 at age 60 years and above (Prior and Waterhouse, 1978) . Earlier studies, however, did not address the issue of incidence rates of first and second neoplasms in subsequent strata of age.
Only more recently has the issue of age incidence of second primary neoplasms been considered. An analysis of the Swedish Family-Cancer Database showed that the incidence of contralateral breast cancer was exceedingly high at age 35-44 years (900 per 100 000), and declined around menopause to rates of about 450 per 100 000, to remain constant thereafter (Vaittinen and Hemminki, 2000) . A similar age distribution was observed for first primary cancers among women who had a subsequent breast cancer (Vaittinen and Hemminki, 2000) . These age incidence curves for first and second breast cancer in women who had contralateral breast cancer were constant at around four to five per 1000 in the Vaud Cancer Registry dataset ( Fig. 1a ) (Levi et al., 2001 ). Furthermore, the age incidence of primary breast cancers among women who had subsequent breast cancers shows no evidence to increase with advancing age, the rates ranging around five per 100 000 across all age groups from 40-49 to 80 years and above (Levi et al., 2001) . In the same population, the incidence of breast cancer was extremely high (of the order of 10 per 1000) following ductal and lobular carcinoma in situ of the breast (Fig. 1b) (Levi et al., 2005a) . This value corresponds well with the incidence of about five per 1000 for subsequent breast cancers, as several women with breast cancer had only one remaining breast at risk (Peto, 1987) . Incidence of in-situ breast cancer is largely influenced by mammography screening in this population (Bulliard et al., 2003) . Incidence of subsequent invasive breast cancers is, however, unlikely to be differentially influenced in various age groups, as intensive surveillance is adopted for all women diagnosed with in-situ breast cancer.
The pattern of incidence of second primary neoplasms with age is less well recognized for neoplasms other than breast, particularly as for only a few cancers is the site of origin not totally removed -and hence remains at riskafter a first primary cancer. Among these primaries is colorectal cancer. The RR of second primary colorectal cancer in the SEER dataset (Shureiqi et al., 2001) and in the Vaud Cancer Registry (Levi et al., 2002) has been shown to decline from about 40 at age 30-39 years to about 1.5 at age 70-89 years, again suggesting that the incidence of second primaries remains constant with age at around three per 1000 (Fig. 1c ). In the Vaud dataset, second colorectal cancer was considered as a new primary when occurring at a different site (right colon, left colon, rectum including recto-sigmoid junction), and on the basis of the pathology report. Again, its incidence is unlikely to be strongly differentially influenced by age.
A similar pattern of risk was observed for oral and pharyngeal cancer (Levi et al., 2006a) . The incidence of first primary cancer increased 20-fold between age 30-39 and 70-89 years, whereas the incidence of second neoplasms did not increase with age, and indeed the incidence rates at age 60-79 years (around 15 per 1000) were lower than those at age 40-59 years ( Fig. 1d ) (around 30 per 1000). As oral cancer in western populations is essentially due to alcohol and tobacco (Franceschi et al., 1990) , this may be due to selective stopping of smoking and/or alcohol drinking in subjects diagnosed with a primary oral and pharyngeal cancer, with the consequent favourable implications for subsequent incidence of the disease (Day et al., 1994; Barbone et al., 1996) . Consequently, the RR of a second primary declined from about 60 below age 50 to 15 at age 70 years or above.
Likewise, for cutaneous malignant neoplasms (CMM), the incidence rates in the Swiss Canton of Vaud increased about five-fold between age 30-34 and 75-79 years. The age-specific incidence rates of second primary CMM, however, did not vary with age, ranging between 1 and 2.5 per 1000 in various subsequent age groups, between age 30-39 and above 80 years (Fig. 1e ) (Levi et al., 2005b) . Consequently, the RR of second CMM was 8.5 around age 50, 5.7 at age 50-59 years, and 3.5 at age 60 years or above. Similarly to the age curve for second CMM, there was no evidence of any systematic increase in incidence with advancing age for primary cancers in the participants who had a subsequent second CMM, the incidence rates ranging around 0.3 per 100 000 across various age groups from 30-39 to 80 years and above.
Incidence of basal cell carcinoma (BCC) is known to be particularly valid in the Vaud population, as a favourable environment for skin cancer registration has long been present in this population, and traditionally a large majority of cutaneous lesions surgically resected are examined by a pathologist (Levi et al., 1988 (Levi et al., , 1995 . In this dataset (Levi et al., 2006b) , the incidence of first BCC of the skin increased about 30-fold from seven per 100 000 at age 30-39 years to 200 per 100 000 at age 70-79 years. The rate of second BCC, however, increased only about three-fold from 31 per 1000 at age 30-39 years to 110 per 1000 at age 70-79 years. Consequently, the RR of second BCC declined from about 14 below age 50 to 7 at age 70 years or above. Thus, the pattern of incidence for second BCC is similar, but less clear than that of other neoplasms. This may, at least in part, be due to the baseline incidence rate of BCC, and in particular, the exceedingly high incidence in participants with previous BCC, with a cumulative risk of second BCC over 20% at 10 years and 40% at 20 years. As in the case of oral and pharyngeal cancer, the lack of strong increase in the incidence of second primary neoplasms with age might be attributed to avoidance of risk factors (e.g. reduced exposure to solar radiation).
Thus, not only for breast cancer but also for all neoplasms for which we were able to analyse the incidence of second neoplasms, the age-incidence curve seems to be constant with age for both primary and second neoplasms in participants who had two neoplasms, rather than increasing with a power of age as do most primary epithelial cancers. Such a power function with age has been interpreted, within the multistage theory of carcinogenesis proposed by Armitage and Doll (1961) , as an indication that the process of carcinogenesis involves the accumulation of several stochastic somatic changes. The constant rate of incidence with age of second primary cancers -but also of primaries in participants with a subsequent second primary -is compatible with the occurrence of a single mutational event in a population of susceptible individuals, that is, just one mutational event away from cancer (Easton, 2000; Peto and Mack, 2000) . Along the same line of reasoning, there is molecular evidence that several pathways need to be disrupted for a cancer to fully develop (Hanahan and Weinberg, 2000) , which is consistent with the power function with age. In contrast, childhood cancers, cancers occurring in adolescence and many familial cancers (e.g. breast cancers in BRCA carriers) do not follow a power function either. So, it is likely that genetic events exist that would modify the 'classic' chain of events requiring several steps.
A possible implication of this observation is that a variable, but potentially large, proportion of cancers arise in very high-risk individuals whose incidence, on average, increases at a high constant level at a predetermined age (Hanahan and Weinberg, 2000) . Family history of cancer has been shown to be a strong predictor of risk of second primary neoplasm (Dong and Hemminki, 2001) .
